Untitled Document
www.expresspharmaonline.com FORTNIGHTLY INSIGHT FOR PHARMA PROFESSIONALS
16-29 February 2008  
Untitled Document
Sections

Market
Management
Nutratrends
Research
Pharma Life

Services
Open Forum
Appointments
Subscribe/Renew
Archives
Editorial Calendar
Media Kit
Contact Us
Network Sites
Express Computer
CIO Decisions
Express Channel Business
Express Hospitality
Express TravelWorld
feBusiness Traveller
Exp. Healthcare Mgmt.
Express Textile
Group Sites
ExpressIndia
Indian Express
Financial Express




     MANAGEMENT - Insight for Managing Pharma
 

Befriending enemies
It really pinches hard when you spend million of dollars and time in research and brand building only to have someone flood the market with copies. ‘Innovator’ pharmaceutical companies have adopted different ways of fighting their traditional enemies. Arshiya Khan explores a few strategies that these companies have up their sleeves

Chasing the right data
Shailesh Gadre, Managing Director, ORG IMS Research talks about their 'evidence based consulting' model and future plans to Viveka Roychowdhury

Healthy temptation for kids
Will Anglo French Drugs' four month old tablet, 'Tedycal' be able to break into the crowded oral solid calcium market? Manjusha Morgaonkar analyses

Phase I specialists
In an industry teeming with clinical research organisations (CROs) of all shapes and sizes, what does it take to stand apart? Veeda Clinical Research does it by specialising in Phase I clinical studies. Dr Maurice Cross, Group Medical Director, Apurva Shah, Group Managing Director and Binoy Gardi, Managing Director are very clear that this will remain their forte in future as well. Viveka Roychowdhury analyses the growth path of this transnational tiger

Budget 2008: Will the dream come true?
Indian pharmaceutical industry is at a crucial juncture and needs the support of a dream budget to accelerate its growth. Manjusha Morgaonkar presents some industry views

Products

Waters' new technology allow analysts to focus on meaningful results
With Waters Corporation's new technology MassPREP Oligonucleotide Separation Technology (OST) Standard, analysts can trust the results obtained after the use of this standard which will allow them to focus time and energy in areas that significantly drive their laboratory objectives.

Transasia Bio-Medicals awarded ISO 13485
Transasia Bio-Medicals, a clinical Diagnostics Segment across the Indian healthcare sector, which aids in diagnosing life threatening diseases faced by the humankind such as, AIDS, tuberculosis, cancer and diabetes etc. has been awarded ISO 13485 (quality management systems for medical devices) by UL India, a certifying body to foster quality assurance and improvement.

New developments in tablet tooling
Indian pharmaceuticals industry has shown commendable growth with large number of generic manufacturing companies penetrating regulated markets.


Untitled Document
Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.